Individuals with gastrointestinal disorders, such as Crohns disease, may have difficulty absorbing B12, increasing their risk of deficiency
The Nature Metabolism study demonstrated that 5-Amino-1MQ's NNMT inhibition directly restored intracellular NAD+ concentrations, which is the upstream driver of its metabolic effects
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT) an enzyme linked to metabolic rate regulation, fat storage, and cellular energy balance
Cellular energy therapies may benefit individuals experiencing fatigue, metabolic decline, or reduced physical performance
Symptoms of pernicious anemia include fatigue, weakness, and neurological changes
Why is the compounded tirzepatide co-formulated with cyanocobalamin (B12)